Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07050628

Assessment of CSF Shunt Flow During Activities of Daily Living and Sleep With a Thermal Measurement Device

This study evaluates the performance of a device for non-invasively assessing cerebrospinal fluid (CSF) shunt flow over multiple measurements performed by a study subject during activities of daily living and sleep

Recruiting

Interested in participating?

Request Info

Key information

Age range

2 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Rhaeos Inc., Chicago, Illinois, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Existing ventricular CSF shunt
  • (Cohort A) A history of stable ventricular size, no shunt revision in the previous 2 years, and no current symptoms of shunt failure
  • (Cohort B) A shunt revision in the previous 7 days and the investigator judges that the patient will likely be discharged within 4 days of the enrollment date
  • Region of intact skin overlying an unambiguously identifiable palpable chronically indwelling ventricular shunt which crosses the clavicle and is appropriate in size for application of the study device
  • Signed informed consent by subject or a parent, legal guardian, health care agent, or surrogate decision maker (according to local statutes)
  • Subject is at least 5 years old but < 22 years old

Exclusion criteria

  • Shunt is not palpable or depth of shunt where the device will be placed is greater than 4 mm per ultrasound evaluation
  • Presence of an interfering open wound or edema in the study device measurement region
  • Subject-reported history of serious adverse skin reactions to silicone-based adhesives
  • Investigator judges that the subject is likely to be lost to follow-up due to unavailability or clinical outcome being unobtainable
  • Investigator judges that the subject is unlikely to successfully take reliable measurements at home
  • Investigator judges that the subject/subject's caretaker would not be able to successfully place the device without assistance
  • Use of the study device would interfere with standard patient care, or emergency surgery that cannot be delayed, or participation in the study will interfere with, or be detrimental to, administration of optimal healthcare to the subject
  • Prior enrollment in this study
  • Participation in any other investigational procedural, pharmaceutical, and/or device study that may influence the collection of valid data under this study

Treatment and study plan

wireless thermal anisotropy measurement device

Device

Wireless wearable thermal anisotropy measurement device designed for use at home will be provided to study subjects in both study arms

Primary outcomes

  1. Adverse Device Effects

    Time frame: 30 days

    The co-primary endpoints in this study are the rate of ADEs and SADEs that occur per wear hour.

Secondary outcomes

  1. ADEs and SADEs per wear period

    Time frame: 30 days

    rate of ADEs and SADEs per wear period

  2. ADEs and SADEs per subject

    Time frame: 30 days

    rate of ADEs and SADEs per subject;

  3. ADEs and SADEs that preclude the continued use of the study device

    Time frame: 30 days

    rate of ADEs and SADEs that preclude the continued use of the study device

  4. Device deficiencies resulting in incomplete monitoring data

    Time frame: 30 days

    percent of device deficiencies resulting in incomplete monitoring data

  5. Local skin reactions per wear session;

    Time frame: 30 days

    number of local skin reactions per wear session;

  6. Usability score

    Time frame: 30 days

    usability score based on post-study survey (1 = easy to use; 5 = difficult to use)

Study contacts

Contact information is provided by the study sponsor or research team.

Anna Somera

CONTACT

[email protected]

855-814-3569

Sponsors and collaborators

Lead sponsor

Rhaeos, Inc.

Industry

Collaborators

  • National Institute of Neurological Disorders and Stroke (NINDS)

Registry information

Official study title

Long-Term Tracking of Fluid Dynamics in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device During Activities of Daily Living Including Sleep

Important dates

Study start
2025
Primary completion
2026
Study completion
2027
First posted
Jul 3, 2025
Registry last updated
Jul 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.